PREG and PME promote microtubule dynamics by possibly affecting the microtubule‐binding of MAP2 and the plus‐end tracking protein CLIP170 with possible therapeutic potential for major depressive disorders and CDKL5 deficiency disorder, both characterised by altered microtubule dynamics. Here, CDKL5 is linked to major depressive disorder.